Avalo Therapeutics Inc (AVTX): going to be a great week with AVTX

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	25
Posts	2063
Boards Moderated	0
Alias Born	12/11/2007

Yosemite Sam

Re: vegasopc post# 556

Monday, 09/25/2023 7:07:39 AM

Monday, September 25, 2023 7:07:39 AM

going to be a great week with AVTX

My post or not a buy or sell recommendation do your own DD.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent AVTX News

Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/13/2024 04:38:48 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 11:33:15 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 11:30:59 AM
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 05/13/2024 11:30:00 AM
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
Avalo Reports 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/29/2024 08:01:00 PM
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million • GlobeNewswire Inc. • 03/27/2024 08:01:00 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/15/2024 02:13:42 AM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 03:02:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:01:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 10:05:25 PM
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split • GlobeNewswire Inc. • 12/27/2023 12:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 09:05:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 09:01:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:01:36 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/07/2023 12:02:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 12:01:08 PM
Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split • GlobeNewswire Inc. • 12/07/2023 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 12:15:21 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 12:21:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 12:04:55 PM
Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/09/2023 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 11:21:15 AM
Avalo Completes Divestiture of AVTX-800 Series • GlobeNewswire Inc. • 10/31/2023 11:00:00 AM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 10/19/2023 08:15:07 PM

More AVTX News

InvestorsHub NewsWire

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover